Association of non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and all-cause mortality in Chinese populations with different baseline risks: A prospective cohort study
Journal of Clinical Lipidology · 2026
DOI: 10.1016/j.jacl.2025.09.009 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Clinical Lipidology, 2026. Verfasst von Mingjie Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China (Drs Yin, Zhai, and Fang). Hauptthemen laut MEDLINE: Atherosclerosis, Cardiovascular Diseases, Cholesterol. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
BACKGROUND: This study, for the first time, stratified a larger sample size of participants according to the Framingham Risk Score and applied a fine-grained classification of non-high-density lipoprotein cholesterol (non-HDL-C) in 20 mg/dL increments, aiming to further analyze the associations of baseline non-HDL-C and its changes with atherosclerotic cardiovascular disease (ASCVD) and all-cause mortality across different baseline risk populations. METHODS: The study included 90,072 low-risk individuals, 77,499 primary prevention individuals, and 15,653 secondary prevention individuals. Using time-varying Cox proportional hazards regression models, we assessed the association of non-HDL-C levels with the risks of ASCVD and all-cause mortality across different baseline risk populations. Furthermore, based on non-HDL-C levels in 2 consecutive measurements, we evaluated the association of changes in non-HDL-C with the risks of ASCVD and all-cause mortality. RESULTS: This study found that non-HDL-C levels below 140 mg/dL in low-risk populations, below 120 mg/dL in primary prevention populations, and below 100 mg/dL in secondary prevention populations were significantly associated with a reduced risk of ASCVD and all-cause mortality. Furthermore, sustained lower non-HDL-C was associated with a 43% reduced risk of ASCVD in low-risk populations and a 27% reduced risk in primary prevention populations, whereas in secondary prevention populations it corresponded to a 25% reduced risk of all-cause mortality. CONCLUSIONS: As baseline risk levels increase, lower non-HDL-C levels are significantly associated with reduced risks of ASCVD and all-cause mortality. Moreover, sustained lower non-HDL-C levels are associated with a significant decrease in ASCVD and all-cause mortality risks across different baseline risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China (Drs Yin, Zhai, and Fang).
- School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (Dr Cui).
- Training Base, Tangshan Gongren Hospital, Tangshan, Hebei, China (Dr Xu).
- Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China (Dr Yang).
- Department of Cardiology, Kailuan General Hospital, Tangshan, Hebei, China (Drs Chen and Wu).
- Second Department of Endocrinology and Metabolism, Tangshan Gongren Hospital, Tangshan, Hebei, China (Drs Sun, Zhen, and Fang).
Förderung
- Natural Science Foundation of Hebei Province
Zitieren
APA
Yin, M., Cui, F., Xu, X., Yang, Y., Chen, S., Sun, Y., Zhen, Y., Zhai, H., Wu, S., & Fang, H. (2026). Association of non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and all-cause mortality in Chinese populations with different baseline risks: A prospective cohort study. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.09.009
Vancouver
Yin M, Cui F, Xu X, Yang Y, Chen S, Sun Y, et al. Association of non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and all-cause mortality in Chinese populations with different baseline risks: A prospective cohort study. Journal of Clinical Lipidology. 2026. doi:10.1016/j.jacl.2025.09.009
BibTeX
@article{Yin2026,
author = {Yin, Mingjie and Cui, Feipeng and Xu, Xiaoyu and Yang, Yuxin and Chen, Shuohua and Sun, Yanan and Zhen, Yanfeng and Zhai, Hongjia and Wu, Shouling and Fang, Hui},
title = {Association of non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and all-cause mortality in Chinese populations with different baseline risks: A prospective cohort study},
journal = {Journal of Clinical Lipidology},
year = {2026},
doi = {10.1016/j.jacl.2025.09.009}
}
EUVIMED